EMD-12585

Single-particle
3.36 Å
EMD-12585 Deposition: 09/03/2021
Map released: 28/04/2021
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-12585

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7nt9 summary report (pdf.gz) Map-7nt9 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)

EMD-12585

Single-particle
3.36 Å
EMD-12585 Deposition: 09/03/2021
Map released: 28/04/2021
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: Ectodomain of spike glycoprotein from SARS-CoV-2 expressed in HEK cells and purified. Data were collected in the presence of excess biliverdin.
Fitted models: 7nt9

Deposition Authors: Rosa A , Pye VE
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.
PUBMED: 33888467
DOI: doi:10.1126/sciadv.abg7607
ISSN: 2375-2548
Grant Support: